Speaker Faculty | 13th Alzheimer’s & Parkinson’s Drug Development Summit

2025 Expert Speaker Faculty

alessandro biffi -13th Alzheimer's & Parkinson's Drug Development Summit

Alessandro Biffi

Associate Vice President

Eli Lilly & Co.

andre matta - 13th Alzheimer's & Parkinson's Drug Development Summit

Andre Matta

Executive Director

Ventus Therapeutics

Andrew Kaplan - 13th Alzheimer's & Parkinson's Drug Development Summit

Andrew Kaplan

Principal Scientist

Bristol Myers Squibb

anick auger - 13th Alzheimer's & Parkinson's Drug Development Summit

Anick Auger

Head of Pharmacology

Ventus Therapeutics

aparna vasanthakuma - 13th Alzheimer's & Parkinson's Drug Development Summitr

Aparna Vasanthakumar

Senior Principal Scientist - Research

Abbvie

Beth Hoffman - 13th Alzheimer's & Parkinson's Drug Development Summit

Beth Hoffman

Chief Executive Officer

Origami Therapeutics, Inc.

Bruce Morimoto - 13th Alzheimer's & Parkinson's Drug Development Summit

Bruce Morimoto

Vice President - Drug Development

Alto Neuroscience

carrie rubel - 13th Alzheimer's & Parkinson's Drug Development Summit

Carrie Rubel

Scientific Director, Biomarkers

Biogen

chloe whitehouse - 13th Alzheimer's & Parkinson's Drug Development Summit

Chloe Whitehouse

Senior Specialist, 3D Technologies

Merck & Co

daniel klamer - 13th Alzheimer's & Parkinson's Drug Development Summit

Daniel Klamer

Vice President of Business Development & Scientific Strategy

Anavex

Dean Petkanas - 13th Alzheimer's & Parkinson's Drug Development Summit

Dean Petkanas

Co-Founder, Chairman & Chief Executive Officer

KannaLife Sciences Inc

Edmond Teng

Senior Group Medical Director

Genentech

Elena Dale - 13th Alzheimer's & Parkinson's Drug Development Summit

Elena Dale

Executive Director, Neuroscience

Bristol Myers Squibb

Eric Siemers - 13th Alzheimer's & Parkinson's Drug Development Summit

Eric Siemers

Chief Medical Officer

Acumen Pharmaceuticals

Fraser Bocell - 13th Alzheimer's & Parkinson's Drug Development Summit

Fraser Bocell

Senior Clinical Outcomes Assessment Scientist

Critical Path Institute (C-Path)

Gül Erdemli- 13th Alzheimer's & Parkinson's Drug Development Summit

Gül Erdemli

Global Program Regulatory Director

Novartis AG

ivana rubino - 13th Alzheimer's & Parkinson's Drug Development Summit

Ivana Rubino

Vice President & Head of Global Medical Neuropsychiatry & Alzheimer's disease

Biogen

Jackie Olley -Williams- 13th Alzheimer's & Parkinson's Drug Development Summit

Jackie Olley-Williams

Senior Data Scientist

Eisai

Janaky Coomaraswamy -Williams- 13th Alzheimer's & Parkinson's Drug Development Summit

Janaky Coomaraswamy

Director, Neuroscience Translational Medicine

Takeda Pharmaceutical Co. Ltd.

Kaare Bjerregaard-Andersen -Williams - 13th Alzheimer's & Parkinson's Drug Development Summit

Kaare Bjerregaard-Andersen

Principal Scientist

Lundbeck

Katie Planey - 13th Alzheimer's & Parkinson's Drug Development Summit

Katie Planey

Chief Executive Officer

Acelot, Inc.

Kenneth Gregory Pugh - 13th Alzheimer's & Parkinson's Drug Development Summit

Kenneth Gregory Pugh

Geriatric Medicine Physician

Norton Healthcare

Luis Oliveira - 13th Alzheimer's & Parkinson's Drug Development Summit

Luis Oliveira

Senior Associate Director - Research Programs

The Michael J. Fox Foundation for Parkinson's Research

Malu Tansey - 13th Alzheimer's & Parkinson's Drug Development Summit

Malú Tansey

Director of the Center for Translational Research in Neurodegenerative Disease

University of Florida

Manuela Polydoro - 13th Alzheimer's & Parkinson's Drug Development Summit

Manuela Polydoro

Vice President, Head of Translational Medicine

Muna Therapeutics

Maria Maccecchini - 13th Alzheimer's & Parkinson's Drug Development Summit

Maria Maccecchini

Chief Executive Officer

Annovis Bio

Melody Libby - 13th Alzheimer's & Parkinson's Drug Development Summit

Melody Libby

Patient Advocacy Lead, Alzheimer's

Biogen

Michael Erkkinen - 13th Alzheimer's & Parkinson's Drug Development Summit

Michael Erkkinen

Instructor in Neurology

Brigham and Women's Hospital

neil cashman - 13th Alzheimer's & Parkinson's Drug Development Summit

Neil Cashman

Chief Scientific Officer & Co-Founder

ProMIS Neurosciences

Pallavi Sachdev - 13th Alzheimer's & Parkinson's Drug Development Summit

Pallavi Sachdev

Executive Director, Translational Medicine

Eisai

paul edison - 13th Alzheimer's & Parkinson's Drug Development Summit

Paul Edison

Professor

Imperial College London

Peter DiBiaso - 13th Alzheimer's & Parkinson's Drug Development Summit

Peter DiBiaso

Patient

The Michael J. Fox Foundation for Parkinson's Research

Ralf Schmid - 13th Alzheimer's & Parkinson's Drug Development Summit

Ralf Schmid

Associate Director, Pre-Clinical Research

Novartis AG

Rebecca Edelmayer - 13th Alzheimer's & Parkinson's Drug Development Summit

Rebecca Edelmayer

Vice President, Scientific Engagement

Alzheimer's Association

Sandi See Tai - 13th Alzheimer's & Parkinson's Drug Development Summit

Sandi See Tai

Chief Development Officer

Lexeo Therapeutics

Sathya Ganesan - 13th Alzheimer's & Parkinson's Drug Development Summit

Sathya Ganesan

US Regulatory Science Lead

UCB S.A.

Sean Pintchovski - 13th Alzheimer's & Parkinson's Drug Development Summit

Sean Pintchovski

Vice President, Biology

AcureX Therapeutics

Shane Hegarty - 13th Alzheimer's & Parkinson's Drug Development Summit

Shane Hegarty

Chief Scientific Officer & Co-Founder

Axonis

shannon leslie - 13th Alzheimer's & Parkinson's Drug Development Summit

Shannon Leslie

Senior Scientist

Johnson & Johnson Services, Inc

Spring Behrouz - 13th Alzheimer's & Parkinson's Drug Development Summit

Spring Behrouz

Co-founder & CEO

Vincere Biosciences

Steven Arnold- 13th Alzheimer's & Parkinson's Drug Development Summit

Steven Arnold

Managing Director, Interdisciplinary Brain Center

Massachusetts General Hopsital

Tammy Dellovade- 13th Alzheimer's & Parkinson's Drug Development Summit

Tammy Dellovade

Senior Research Fellow, Discovery Neuroscience

Abbvie

Tony Bannon - 13th Alzheimer's & Parkinson's Drug Development Summit

Tony Bannon

Senior Director - Scientific, Precision Medicine & Neuroscience

Abbvie

Tricia Thornton-Wells

Senior Director & Compound Development Team Leader

Johnson & Johnson Services, Inc

Urs Langen - 13th Alzheimer's & Parkinson's Drug Development Summit

Urs Langen

Lab Head

Roche

will shrader - 13th Alzheimer's & Parkinson's Drug Development Summit

William Shrader

Cofounder & Chief Scientific Officer

AcureX Therapeutics

Xavier Langlois - 13th Alzheimer's & Parkinson's Drug Development Summit

Xavier Langlois

Research Fellow & Head of Tau Pathobiology

Abbvie

FULL EVENT GUIDE

PRE-CONFERENCE DAY